Study recommends Oxaliplatin-Fluoropyrimidine Combo as a standard-of-care treatment for Stage III MSI / dMMR Colon Cancer
A meta-analysis of individual patient data from the ACCENT database showed that the combination of oxaliplatin plus fluoropyrimidine (FP) should be considered as a standard-of-care diagnostic treat…
